The debut, progression and maintenance of skin disease are related to stress(acne, alopecia areata, atopic dermatitis, lichen planus, psoriasis, urticaria, vitiligo, herpes, hyperhidrosis, pemphigus, rosacea or seborr...The debut, progression and maintenance of skin disease are related to stress(acne, alopecia areata, atopic dermatitis, lichen planus, psoriasis, urticaria, vitiligo, herpes, hyperhidrosis, pemphigus, rosacea or seborrheic dermatitis). Environmental, socio-professional, life events are representing external factors. Personality, previous experiences, traits of anxiety are individual factors influencing the state of stress. Perceived stress could be more harmful especially in "high reactors" to stress. Coping abilities to stress could be increased in social programs. There was a recent interest in measuring the quality of life in the last years. There are dermatology and disease specific questionnaires that could help. Out-patients have less time to wait for very sophisticated procedures. They expect faster results. For simple, acute diseases it is important to have a good communication and good understanding of the instructions to get results as soon as possible. For chronic diseases a strong long-term alliance is needed, so the patients should revisit for his benefit and not for giving up. Small questions regarding potential stressful events, impact on the quality of life, stigmatization, the level of symptoms(pruritus), psychiatric comorbidities(anxiety, depression), short questionnaires for quality of life give us a better picture, personalize the doctorpatient relationship and could influence the choice of treatment. Many skin disorders could be seen from a psychosomatic point of view and the final goal, especially for the chronic diseases, is to improve through our treatments the impact on the quality of patient's life.展开更多
The significance of patient-reported outcomes（PROs） is increasingly being acknowledged and quality of life（QOL） has become an integral element of the assessment of overall burden of disease.Psoriasis has been know...The significance of patient-reported outcomes（PROs） is increasingly being acknowledged and quality of life（QOL） has become an integral element of the assessment of overall burden of disease.Psoriasis has been known for its major impact on patients＇ QOL and various generic,dermatology-specific and psoriasis-specific self- administered psychometric instruments have been used over the years to assess the QOL of psoriasis patients.However,the Dermatology Life Quality Index（DLQI） is the most widely used QOL measure among these measures in psoriasis-related clinical trials. A number of topical and systemic treatments have been used in the management of psoriasis and lately biologics have emerged as a new and promising treatment modality for difficuIt-to-treat psoriasis.The evidence on the efficacy of these agents has been growing dramatically with QOL being used as one of the primary outcome measures in many clinical trials.The aim of this paper is to give an overview of the use of the DLQI as an outcome measure for assessing the QOL impact of biologies on psoriasis patients.Furthermore,the efficacy of five commonly used biologics has been compared in terms of their ability to improve the QOL assessed by the DLQI.This review has revealed that there is a variation in the efficacy of various biologies in terms of QOL improvement with the mean reduction in the DLQI scores being highest for ustekinumab 90 mg（mean DLQI score reduction=9.5）,followed by infliximab（8.5）,etanercept 50 mg,twice a week（7.7）,adalimumab（6.3）,and alefacept（4.0）.展开更多
目的:评价皮肤病生活质量指数(dermatology life quality index,DLQI)与非特异性生活质量量表(the short form-36 healthsurvey,SF-36)在评估手部湿疹患者生活质量时的效果。方法:采用简体中文版DLQI和SF-36量表同时对108例手部湿疹患者...目的:评价皮肤病生活质量指数(dermatology life quality index,DLQI)与非特异性生活质量量表(the short form-36 healthsurvey,SF-36)在评估手部湿疹患者生活质量时的效果。方法:采用简体中文版DLQI和SF-36量表同时对108例手部湿疹患者(病例组)及102例健康人群(对照组)的生活质量进行评估,并对评估结果进行统计学分析。结果:①DLQI研究结果:病例组评分远高于对照组(P<0.001),手部湿疹对患者的生理及社会活动影响最大(P<0.05),对人际关系影响最小(P<0.05),性别的差异对生活质量的影响无统计学意义(P>0.05)。②SF-36量表研究结果:病例组女性同对照组女性相比各个维度的分值均较低(P<0.05),而病例组男性同对照组男性相比仅在生理职能、躯体疼痛和躯体健康总评有较低的分数(P<0.001);多元方差分析结果表明在生理功能、活力、情感职能、心理健康、心理健康总评维度,性别差异均具有统计学意义(P<0.05),各维度在年龄方面,只有生理功能存在趋势性,年龄越大生理功能越低(P<0.05);在生理功能(PF)和躯体健康总评(PCS)维度,年龄和性别存在明显的交互作用(P<0.05)。结论:手部湿疹严重影响了患者的生活质量,SF-36量表较DLQI更适用于评估手部湿疹患者的生活质量。展开更多
目的观察温针灸联合放血疗法对痤疮患者皮损程度、皮肤病生活质量指数(dermatology life quality index,DLQI)评分及复发率的影响。方法 120例湿热型痤疮患者随机分为观察组和对照组,每组60例。对照组采用放血疗法,观察组在对照组基础...目的观察温针灸联合放血疗法对痤疮患者皮损程度、皮肤病生活质量指数(dermatology life quality index,DLQI)评分及复发率的影响。方法 120例湿热型痤疮患者随机分为观察组和对照组,每组60例。对照组采用放血疗法,观察组在对照组基础上联合温针灸治疗。观察两组患者治疗前后皮损程度、DLQI评分、中医症候评分变化,比较两组的临床疗效、不良反应发生率及复发率。结果观察组总有效率显著高于对照组(P<0.05)。两组治疗后皮损个数显著减少(P<0.05),且观察组皮损个数少于对照组(P<0.05),皮损减少率大于对照组(P<0.05)。治疗后两组DLQI评分、中医症候评分均显著降低(P<0.05),且观察组低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。治疗组复发率显著低于对照组(P<0.05)。结论温针灸联合放血疗法治疗湿热型痤疮疗效佳,不良反应率低,复发率低,疗效稳定。展开更多
目的:探讨清热除湿汤加减联合强脉冲光(Intense pulsed light,IPL)治疗轻中度脾胃湿热型玫瑰痤疮的疗效。方法:选取2018年2月-2021年2月在笔者医院确诊的100例轻中度脾胃湿热型玫瑰痤疮患者,采用简单随机分组将患者分为观察组和对照组,...目的:探讨清热除湿汤加减联合强脉冲光(Intense pulsed light,IPL)治疗轻中度脾胃湿热型玫瑰痤疮的疗效。方法:选取2018年2月-2021年2月在笔者医院确诊的100例轻中度脾胃湿热型玫瑰痤疮患者,采用简单随机分组将患者分为观察组和对照组,每组50例。对照组采用IPL治疗,观察组采用清热除湿汤加减联合IPL治疗,均持续治疗4个月。评价患者疗效和治疗前后中医证候积分。分别于治疗前后采用玫瑰痤疮医师全球评分(Physician’s global assessment,PGA)对患者玫瑰痤疮情况进行评分;分别于治疗前、治疗后2个月和治疗后4个月,使用皮肤病生活质量指数量表(Dermatology life quality index,DLQI)评估患者生活质量。记录两组治疗期间的不良反应发生情况。结果:观察组治疗有效率为92.00%,明显高于对照组的76.00%,差异有统计学意义(P<0.05);治疗后,观察组中医证候积分明显低于对照组,观察组患者玫瑰痤疮改善程度明显优于对照组,生活质量明显高于对照组,差异均有统计学意义(P<0.05)。观察组患者治疗期间的不良反应发生率为10.00%,与对照组(14.00%)比较差异无统计学意义(P>0.05)。结论:清热除湿汤加减联合IPL治疗轻中度脾胃湿热型玫瑰痤疮可明显提高临床疗效,改善患者生活质量。展开更多
目的:研究强脉冲光联合A型肉毒毒素治疗玫瑰痤疮的疗效及对患者皮肤屏障功能、生活质量的影响。方法:收集2020年3月-2021年12月笔者医院收治的124例玫瑰痤疮患者以随机数字表法分组,对照1组(41例)接受A型肉毒毒素治疗,对照2组(42例)接...目的:研究强脉冲光联合A型肉毒毒素治疗玫瑰痤疮的疗效及对患者皮肤屏障功能、生活质量的影响。方法:收集2020年3月-2021年12月笔者医院收治的124例玫瑰痤疮患者以随机数字表法分组,对照1组(41例)接受A型肉毒毒素治疗,对照2组(42例)接受强脉冲光治疗,观察组(41例)接受强脉冲光联合A型肉毒毒素治疗。记录疗效、不良反应、1年复发情况、治疗前后症状积分、皮肤屏障功能、皮肤病生活质量指数问卷(Dermatology life quality index,DLQI)。结果:观察组的有效率高于对照1组、对照2组(P<0.05)。治疗后,观察组的症状积分、皮肤屏障功能(经皮水分丢失量、皮肤含水量、皮脂含量)及DLQI均优于对照1组和对照2组(P<0.05),对照1组与对照2组的症状积分、皮肤屏障功能、DLQI差异无统计学差异(P>0.05)。三组不良反应差异无统计学差异(P>0.05)。观察组的1年复发率低于对照1组、对照2组(P<0.05)。结论:强脉冲光联合A型肉毒毒素治疗玫瑰痤疮能够提高疗效,改善患者皮肤屏障功能和DLQI。展开更多
Objective:Psoriasis is a chronic inflammatory systemic disease that severely impacts patients’ quality of life (QoL) and psychological health.While biologics have been shown to be effective in treating psoriatic lesi...Objective:Psoriasis is a chronic inflammatory systemic disease that severely impacts patients’ quality of life (QoL) and psychological health.While biologics have been shown to be effective in treating psoriatic lesions,thus improving QoL,real-life data regarding such effects remain scant.We administered a repeated cross-sectional survey to assess the effects of 8 weeks of biologics treatment on the QoL and mental health status of patients with moderate-to-severe plaque psoriasis.Methods:From March to May 2022,patients with moderate-to-severe plaque psoriasis were enrolled and treated with biologics in the outpatient clinic at the Dermatology Hospital of Southern Medical University.Assessments were performed before treatment and after 4 and 8 weeks of treatment with biologics.Psoriasis severity,QoL,and mental health status were evaluated using the Psoriasis Area and Severity Index (PASI),Dermatology Life Quality Index (DLQI),36-Item Short-form Health Survey (SF-36),and Hospital Anxiety and Depression Scale (HADS).A multivariate generalized estimating equations (GEE) analysis was used to account for repeated measures and to determine the effects of treatment duration and type of biological agent on relevant indicators.Results:Among the 78 enrolled patients,the ranges of pretreatment scores were 4.6 to 46.8 for the PASI,1 to 30 for the DLQI,31.5 to 100.0 for the physical component score (PCS) of the SF-36,16.6 to 100.0 for the mental component score (MCS) of the SF-36,0 to 15 for the HADS-A,and 0 to 17 for the HADS-D.After 8 weeks of biologics treatment,98.7% (77/78) of patients had obtained PASI 75.All assessed scores changed over time (GEE,P < 0.001).Moreover,there were group-by-time interaction effects for the DLQI score (GEE,P = 0.023) and PCS (GEE,P = 0.029).The HADS-A and HADS-D scores were both decreased at week 8 compared with pretreatment values.Correlation analyses revealed that higher DLQI scores were associated with lower levels of QoL and higher levels of anxiety or depression.Conclusion:Biologics are not only effective in the treatment of skin lesions but also exert beneficial effects upon the QoL and mental health of patients with psoriasis as determined in the short-term assessments conducted in this study.展开更多
目的评估皮肤病生活质量指数（dermatology life quality index，DLQ1）在寻常性银屑病患者进行临床研究中的临床最小重要差值（minimal clinical important differences，MCID）。方法依托在2个中心进行的临床试验“耳穴贴压加西药局...目的评估皮肤病生活质量指数（dermatology life quality index，DLQ1）在寻常性银屑病患者进行临床研究中的临床最小重要差值（minimal clinical important differences，MCID）。方法依托在2个中心进行的临床试验“耳穴贴压加西药局部用药治疗寻常性银屑病的随机对照研究”（注册号为：ChiCTR—TRC．14004916）进行评估。该研究纳入100例合格病例，随机分成治疗组（51例）采用耳穴叠加得肤宝外用治疗和对照组（49例）单纯采用得肤宝外用治疗。在治疗的0周、4周让患者自行填写DLQI进行生活质量评估，并采用分布法和效标法分别对DLQI的耳穴治疗寻常性银屑病患者中MCID进行估算。结果在这个临床研究中，采用分布法估算的DLQI的MCID波动于0．23—2．58之间，采用效标法估算的MCID值为2．53。结论本研究中DLQI的临床最小重要差异值为2．53，代表患者评分下降2．53时皮损达到好转；使用效标法和分布法评估DLQI的MCID，对临床及量表研究具有重要的参考价值。展开更多
目的研究银屑病对患者健康相关生活质量(health-related quality of life,HRQOL)的影响,以及银屑病严重程度与生活质量的关系。方法对本院2013年2月-2014年3月124例(进行期53例,稳定期71例)门诊银屑病患者进行调查,对银屑病患者的严重...目的研究银屑病对患者健康相关生活质量(health-related quality of life,HRQOL)的影响,以及银屑病严重程度与生活质量的关系。方法对本院2013年2月-2014年3月124例(进行期53例,稳定期71例)门诊银屑病患者进行调查,对银屑病患者的严重程度进行皮损面积和严重程度指数(psoriasis area and severity index,PASI)评估,采用皮肤病生活质量量表(dermatology life quality index,DLQI)和简明健康状况量表(generic 36-item short-form,SF-36)评估患者生活质量。结果银屑病患者PASI平均11.6±6.1,平均DLQI得分7.4±5.8,平均SF-36得分53.8±15.0;进行期患者PASI、DLQI得分显著高于稳定期患者(P<0.01),SF-36得分显著低于稳定期患者(P<0.01),表明进行期患者生活质量显著低于稳定期;银屑病患者DLQI得分与PASI呈显著正相关(r=0.645,P=0.000),SF-36得分与PASI呈负相关(r=-0.209,P=0.020),DLQI与SF-36无相关性(r=-0.114,P=0.208)。结论银屑病会降低患者生活质量;进行期患者生活质量显著低于稳定期患者;生活质量与疾病严重程度显著相关。展开更多
目的:评价男性雄激素性秃发(androgenetic alopecia,AGA)患者生活质量。方法:采用皮肤病生活质量指数(dermatology life quality index,DLQI)量表对165例男性AGA患者生活质量进行评估,并对问卷结果进行信度、效度及相关因素分析。结果:...目的:评价男性雄激素性秃发(androgenetic alopecia,AGA)患者生活质量。方法:采用皮肤病生活质量指数(dermatology life quality index,DLQI)量表对165例男性AGA患者生活质量进行评估,并对问卷结果进行信度、效度及相关因素分析。结果:共调查165例AGA患者,DLQI总分平均为(5.50±4.44)分,该评分在年龄、婚姻及脱发严重程度这3个方面差异有统计学意义。结论:AGA影响了男性患者的生活质量。患者的生活质量与年龄、脱发严重程度及婚姻状态呈负相关。展开更多
文摘The debut, progression and maintenance of skin disease are related to stress(acne, alopecia areata, atopic dermatitis, lichen planus, psoriasis, urticaria, vitiligo, herpes, hyperhidrosis, pemphigus, rosacea or seborrheic dermatitis). Environmental, socio-professional, life events are representing external factors. Personality, previous experiences, traits of anxiety are individual factors influencing the state of stress. Perceived stress could be more harmful especially in "high reactors" to stress. Coping abilities to stress could be increased in social programs. There was a recent interest in measuring the quality of life in the last years. There are dermatology and disease specific questionnaires that could help. Out-patients have less time to wait for very sophisticated procedures. They expect faster results. For simple, acute diseases it is important to have a good communication and good understanding of the instructions to get results as soon as possible. For chronic diseases a strong long-term alliance is needed, so the patients should revisit for his benefit and not for giving up. Small questions regarding potential stressful events, impact on the quality of life, stigmatization, the level of symptoms(pruritus), psychiatric comorbidities(anxiety, depression), short questionnaires for quality of life give us a better picture, personalize the doctorpatient relationship and could influence the choice of treatment. Many skin disorders could be seen from a psychosomatic point of view and the final goal, especially for the chronic diseases, is to improve through our treatments the impact on the quality of patient's life.
文摘The significance of patient-reported outcomes（PROs） is increasingly being acknowledged and quality of life（QOL） has become an integral element of the assessment of overall burden of disease.Psoriasis has been known for its major impact on patients＇ QOL and various generic,dermatology-specific and psoriasis-specific self- administered psychometric instruments have been used over the years to assess the QOL of psoriasis patients.However,the Dermatology Life Quality Index（DLQI） is the most widely used QOL measure among these measures in psoriasis-related clinical trials. A number of topical and systemic treatments have been used in the management of psoriasis and lately biologics have emerged as a new and promising treatment modality for difficuIt-to-treat psoriasis.The evidence on the efficacy of these agents has been growing dramatically with QOL being used as one of the primary outcome measures in many clinical trials.The aim of this paper is to give an overview of the use of the DLQI as an outcome measure for assessing the QOL impact of biologies on psoriasis patients.Furthermore,the efficacy of five commonly used biologics has been compared in terms of their ability to improve the QOL assessed by the DLQI.This review has revealed that there is a variation in the efficacy of various biologies in terms of QOL improvement with the mean reduction in the DLQI scores being highest for ustekinumab 90 mg（mean DLQI score reduction=9.5）,followed by infliximab（8.5）,etanercept 50 mg,twice a week（7.7）,adalimumab（6.3）,and alefacept（4.0）.
文摘目的:评价皮肤病生活质量指数(dermatology life quality index,DLQI)与非特异性生活质量量表(the short form-36 healthsurvey,SF-36)在评估手部湿疹患者生活质量时的效果。方法:采用简体中文版DLQI和SF-36量表同时对108例手部湿疹患者(病例组)及102例健康人群(对照组)的生活质量进行评估,并对评估结果进行统计学分析。结果:①DLQI研究结果:病例组评分远高于对照组(P<0.001),手部湿疹对患者的生理及社会活动影响最大(P<0.05),对人际关系影响最小(P<0.05),性别的差异对生活质量的影响无统计学意义(P>0.05)。②SF-36量表研究结果:病例组女性同对照组女性相比各个维度的分值均较低(P<0.05),而病例组男性同对照组男性相比仅在生理职能、躯体疼痛和躯体健康总评有较低的分数(P<0.001);多元方差分析结果表明在生理功能、活力、情感职能、心理健康、心理健康总评维度,性别差异均具有统计学意义(P<0.05),各维度在年龄方面,只有生理功能存在趋势性,年龄越大生理功能越低(P<0.05);在生理功能(PF)和躯体健康总评(PCS)维度,年龄和性别存在明显的交互作用(P<0.05)。结论:手部湿疹严重影响了患者的生活质量,SF-36量表较DLQI更适用于评估手部湿疹患者的生活质量。
文摘目的观察温针灸联合放血疗法对痤疮患者皮损程度、皮肤病生活质量指数(dermatology life quality index,DLQI)评分及复发率的影响。方法 120例湿热型痤疮患者随机分为观察组和对照组,每组60例。对照组采用放血疗法,观察组在对照组基础上联合温针灸治疗。观察两组患者治疗前后皮损程度、DLQI评分、中医症候评分变化,比较两组的临床疗效、不良反应发生率及复发率。结果观察组总有效率显著高于对照组(P<0.05)。两组治疗后皮损个数显著减少(P<0.05),且观察组皮损个数少于对照组(P<0.05),皮损减少率大于对照组(P<0.05)。治疗后两组DLQI评分、中医症候评分均显著降低(P<0.05),且观察组低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。治疗组复发率显著低于对照组(P<0.05)。结论温针灸联合放血疗法治疗湿热型痤疮疗效佳,不良反应率低,复发率低,疗效稳定。
文摘目的:探讨清热除湿汤加减联合强脉冲光(Intense pulsed light,IPL)治疗轻中度脾胃湿热型玫瑰痤疮的疗效。方法:选取2018年2月-2021年2月在笔者医院确诊的100例轻中度脾胃湿热型玫瑰痤疮患者,采用简单随机分组将患者分为观察组和对照组,每组50例。对照组采用IPL治疗,观察组采用清热除湿汤加减联合IPL治疗,均持续治疗4个月。评价患者疗效和治疗前后中医证候积分。分别于治疗前后采用玫瑰痤疮医师全球评分(Physician’s global assessment,PGA)对患者玫瑰痤疮情况进行评分;分别于治疗前、治疗后2个月和治疗后4个月,使用皮肤病生活质量指数量表(Dermatology life quality index,DLQI)评估患者生活质量。记录两组治疗期间的不良反应发生情况。结果:观察组治疗有效率为92.00%,明显高于对照组的76.00%,差异有统计学意义(P<0.05);治疗后,观察组中医证候积分明显低于对照组,观察组患者玫瑰痤疮改善程度明显优于对照组,生活质量明显高于对照组,差异均有统计学意义(P<0.05)。观察组患者治疗期间的不良反应发生率为10.00%,与对照组(14.00%)比较差异无统计学意义(P>0.05)。结论:清热除湿汤加减联合IPL治疗轻中度脾胃湿热型玫瑰痤疮可明显提高临床疗效,改善患者生活质量。
文摘目的:研究强脉冲光联合A型肉毒毒素治疗玫瑰痤疮的疗效及对患者皮肤屏障功能、生活质量的影响。方法:收集2020年3月-2021年12月笔者医院收治的124例玫瑰痤疮患者以随机数字表法分组,对照1组(41例)接受A型肉毒毒素治疗,对照2组(42例)接受强脉冲光治疗,观察组(41例)接受强脉冲光联合A型肉毒毒素治疗。记录疗效、不良反应、1年复发情况、治疗前后症状积分、皮肤屏障功能、皮肤病生活质量指数问卷(Dermatology life quality index,DLQI)。结果:观察组的有效率高于对照1组、对照2组(P<0.05)。治疗后,观察组的症状积分、皮肤屏障功能(经皮水分丢失量、皮肤含水量、皮脂含量)及DLQI均优于对照1组和对照2组(P<0.05),对照1组与对照2组的症状积分、皮肤屏障功能、DLQI差异无统计学差异(P>0.05)。三组不良反应差异无统计学差异(P>0.05)。观察组的1年复发率低于对照1组、对照2组(P<0.05)。结论:强脉冲光联合A型肉毒毒素治疗玫瑰痤疮能够提高疗效,改善患者皮肤屏障功能和DLQI。
文摘Objective:Psoriasis is a chronic inflammatory systemic disease that severely impacts patients’ quality of life (QoL) and psychological health.While biologics have been shown to be effective in treating psoriatic lesions,thus improving QoL,real-life data regarding such effects remain scant.We administered a repeated cross-sectional survey to assess the effects of 8 weeks of biologics treatment on the QoL and mental health status of patients with moderate-to-severe plaque psoriasis.Methods:From March to May 2022,patients with moderate-to-severe plaque psoriasis were enrolled and treated with biologics in the outpatient clinic at the Dermatology Hospital of Southern Medical University.Assessments were performed before treatment and after 4 and 8 weeks of treatment with biologics.Psoriasis severity,QoL,and mental health status were evaluated using the Psoriasis Area and Severity Index (PASI),Dermatology Life Quality Index (DLQI),36-Item Short-form Health Survey (SF-36),and Hospital Anxiety and Depression Scale (HADS).A multivariate generalized estimating equations (GEE) analysis was used to account for repeated measures and to determine the effects of treatment duration and type of biological agent on relevant indicators.Results:Among the 78 enrolled patients,the ranges of pretreatment scores were 4.6 to 46.8 for the PASI,1 to 30 for the DLQI,31.5 to 100.0 for the physical component score (PCS) of the SF-36,16.6 to 100.0 for the mental component score (MCS) of the SF-36,0 to 15 for the HADS-A,and 0 to 17 for the HADS-D.After 8 weeks of biologics treatment,98.7% (77/78) of patients had obtained PASI 75.All assessed scores changed over time (GEE,P < 0.001).Moreover,there were group-by-time interaction effects for the DLQI score (GEE,P = 0.023) and PCS (GEE,P = 0.029).The HADS-A and HADS-D scores were both decreased at week 8 compared with pretreatment values.Correlation analyses revealed that higher DLQI scores were associated with lower levels of QoL and higher levels of anxiety or depression.Conclusion:Biologics are not only effective in the treatment of skin lesions but also exert beneficial effects upon the QoL and mental health of patients with psoriasis as determined in the short-term assessments conducted in this study.
文摘目的评估皮肤病生活质量指数（dermatology life quality index，DLQ1）在寻常性银屑病患者进行临床研究中的临床最小重要差值（minimal clinical important differences，MCID）。方法依托在2个中心进行的临床试验“耳穴贴压加西药局部用药治疗寻常性银屑病的随机对照研究”（注册号为：ChiCTR—TRC．14004916）进行评估。该研究纳入100例合格病例，随机分成治疗组（51例）采用耳穴叠加得肤宝外用治疗和对照组（49例）单纯采用得肤宝外用治疗。在治疗的0周、4周让患者自行填写DLQI进行生活质量评估，并采用分布法和效标法分别对DLQI的耳穴治疗寻常性银屑病患者中MCID进行估算。结果在这个临床研究中，采用分布法估算的DLQI的MCID波动于0．23—2．58之间，采用效标法估算的MCID值为2．53。结论本研究中DLQI的临床最小重要差异值为2．53，代表患者评分下降2．53时皮损达到好转；使用效标法和分布法评估DLQI的MCID，对临床及量表研究具有重要的参考价值。
文摘目的研究银屑病对患者健康相关生活质量(health-related quality of life,HRQOL)的影响,以及银屑病严重程度与生活质量的关系。方法对本院2013年2月-2014年3月124例(进行期53例,稳定期71例)门诊银屑病患者进行调查,对银屑病患者的严重程度进行皮损面积和严重程度指数(psoriasis area and severity index,PASI)评估,采用皮肤病生活质量量表(dermatology life quality index,DLQI)和简明健康状况量表(generic 36-item short-form,SF-36)评估患者生活质量。结果银屑病患者PASI平均11.6±6.1,平均DLQI得分7.4±5.8,平均SF-36得分53.8±15.0;进行期患者PASI、DLQI得分显著高于稳定期患者(P<0.01),SF-36得分显著低于稳定期患者(P<0.01),表明进行期患者生活质量显著低于稳定期;银屑病患者DLQI得分与PASI呈显著正相关(r=0.645,P=0.000),SF-36得分与PASI呈负相关(r=-0.209,P=0.020),DLQI与SF-36无相关性(r=-0.114,P=0.208)。结论银屑病会降低患者生活质量;进行期患者生活质量显著低于稳定期患者;生活质量与疾病严重程度显著相关。
文摘目的:评价男性雄激素性秃发(androgenetic alopecia,AGA)患者生活质量。方法:采用皮肤病生活质量指数(dermatology life quality index,DLQI)量表对165例男性AGA患者生活质量进行评估,并对问卷结果进行信度、效度及相关因素分析。结果:共调查165例AGA患者,DLQI总分平均为(5.50±4.44)分,该评分在年龄、婚姻及脱发严重程度这3个方面差异有统计学意义。结论:AGA影响了男性患者的生活质量。患者的生活质量与年龄、脱发严重程度及婚姻状态呈负相关。
